Prolight Diagnostics AB

Equities

PRLD

SE0003618230

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
0.12 ^SEK	-9.09%		-15.49%	-60.13%

May. 17	Prolight Diagnostics Gets SEK17 Million Grant to Advance Product Development	MT
Feb. 21	Prolight Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Prolight Diagnostics AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021

August 30, 2021

Prolight Diagnostics AB publ announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced net loss was SEK 2.131 million compared to SEK 574,204 a year ago. For the half year, net loss was SEK 3.591 million compared to SEK 2.037 million a year ago.

Latest news about Prolight Diagnostics AB

Prolight Diagnostics Gets SEK17 Million Grant to Advance Product Development	May. 17	MT
Prolight Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20	CI
Prolight Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 20	CI
Prolight Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 26	CI
Prolight Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-29	CI
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Prolight Diagnostics AB Reports Earnings Results for the Ten Months Ended December 31, 2022	23-04-19	CI
Prolight Diagnostics AB Reports Earnings Results for the Third Quarter and Seven Months Ended September 30, 2022	22-11-29	CI
Prolight Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-28	CI
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-19	CI
Prolight Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-21	CI
Prolight Diagnostics AB signed an agreement to acquire Psyros Diagnostics Ltd for SEK 65 million.	22-01-19	CI
Prolight Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-22	CI
Prolight Diagnostics AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-30	CI
Prolight Diagnostics AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-04	CI
Prolight Diagnostics AB Publ Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-09	CI

Chart Prolight Diagnostics AB

Duration

Period

More charts

Company Profile

Prolight Diagnostics AB (publ) is a Sweden-based medical technology company. Together with Technology Partners, the Company develops patient-close test systems based on patented technology, for use in so-called Point of Care Testing (POCT). POCT tests are performed outside the traditional hospital laboratory, small mobile instruments enable testing near the patient and provide quick test answers. The Company focuses on the heart marker troponin.

Sector

Biotechnology & Medical Research

Calendar

2024-05-26 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
PROLIGHT DIAGNOSTICS AB	-60.13%	5.59M
EXACT SCIENCES CORPORATION	-31.39%	9.87B
GUARDANT HEALTH, INC.	-16.78%	2.75B
BGI GENOMICS CO., LTD.	-17.50%	2.13B
VERACYTE, INC.	-24.28%	1.65B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+66.87%	1.47B
CAREDX, INC	+37.17%	811M
SEEGENE, INC.	-5.02%	733M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-29.69%	510M
CURIOX BIOSYSTEMS CO., LTD	+0.20%	300M

Bio Diagnostics & Testing